Concepedia

Natalizumab therapy is associated with changes in serum JC virus antibody indices over time

John Peters, Eric Williamson

Journal of Neurology · 2017 · 11 citations · 6 references

DOI

Concepts

References

6

Anti–JC virus antibody levels in serum or plasma further define risk of natalizumab‐associated progressive multifocal leukoencephalopathy

Tatiana Plavina, Meena Subramanyam, Gary Bloomgren et al. · Annals of Neurology · 2014 · 438 citations · Full text

, , +15

Anti‐JC virus antibodies: Implications for PML Risk Stratification

Leonid Gorelik, Michaela Lerner, Sarah A. Bixler et al. · Annals of Neurology · 2010 · 431 citations

, , +14

A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification

Peter P. Lee, Tatiana Plavina, Albert Castro et al. · Journal of Clinical Virology · 2013 · 165 citations

, , +17

Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort

Tomas Olsson, Anat Achiron, Lars Alfredsson et al. · Multiple Sclerosis Journal · 2013 · 103 citations

, , +10

Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values

Nicholas Schwab, Tilman Schneider‐Hohendorf, Béatrice Pignolet et al. · Neurology Neuroimmunology & Neuroinflammation · 2016 · 77 citations · Full text

, , +16